BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 1845900)

  • 1. Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene.
    Zimber-Strobl U; Suentzenich KO; Laux G; Eick D; Cordier M; Calender A; Billaud M; Lenoir GM; Bornkamm GW
    J Virol; 1991 Jan; 65(1):415-23. PubMed ID: 1845900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23.
    Cordier M; Calender A; Billaud M; Zimber U; Rousselet G; Pavlish O; Banchereau J; Tursz T; Bornkamm G; Lenoir GM
    J Virol; 1990 Mar; 64(3):1002-13. PubMed ID: 2154588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different patterns of Epstein-Barr virus gene expression and of cytotoxic T-cell recognition in B-cell lines infected with transforming (B95.8) or nontransforming (P3HR1) virus strains.
    Murray RJ; Young LS; Calender A; Gregory CD; Rowe M; Lenoir GM; Rickinson AB
    J Virol; 1988 Mar; 62(3):894-901. PubMed ID: 2828684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
    Wang F; Gregory C; Sample C; Rowe M; Liebowitz D; Murray R; Rickinson A; Kieff E
    J Virol; 1990 May; 64(5):2309-18. PubMed ID: 2157887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter.
    Zimber-Strobl U; Kremmer E; Grässer F; Marschall G; Laux G; Bornkamm GW
    EMBO J; 1993 Jan; 12(1):167-75. PubMed ID: 8381349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus (EBV) nuclear-antigen-2-induced up-regulation of CD21 and CD23 molecules is dependent on a permissive cellular context.
    Cordier-Bussat M; Billaud M; Calender A; Lenoir GM
    Int J Cancer; 1993 Jan; 53(1):153-60. PubMed ID: 8416201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.
    Schaefer BC; Woisetschlaeger M; Strominger JL; Speck SH
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6550-4. PubMed ID: 1713681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of an Epstein-Barr virus nuclear antigen 2-responsive cis element in the bidirectional promoter region of latent membrane protein and terminal protein 2 genes.
    Laux G; Dugrillon F; Eckert C; Adam B; Zimber-Strobl U; Bornkamm GW
    J Virol; 1994 Nov; 68(11):6947-58. PubMed ID: 7933076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low expression of lymphocyte function-associated antigen (LFA)-1 and LFA-3 adhesion molecules is a common trait in Burkitt's lymphoma associated with and not associated with Epstein-Barr virus.
    Billaud M; Rousset F; Calender A; Cordier M; Aubry JP; Laisse V; Lenoir GM
    Blood; 1990 May; 75(9):1827-33. PubMed ID: 1691936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2.
    Strobl LJ; Höfelmayr H; Marschall G; Brielmeier M; Bornkamm GW; Zimber-Strobl U
    J Virol; 2000 Feb; 74(4):1727-35. PubMed ID: 10644343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein.
    Abbot SD; Rowe M; Cadwallader K; Ricksten A; Gordon J; Wang F; Rymo L; Rickinson AB
    J Virol; 1990 May; 64(5):2126-34. PubMed ID: 2157875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of bcl-2 in Burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes.
    Finke J; Fritzen R; Ternes P; Trivedi P; Bross KJ; Lange W; Mertelsmann R; Dölken G
    Blood; 1992 Jul; 80(2):459-69. PubMed ID: 1378321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the Epstein-Barr virus terminal protein gene products in latently infected lymphocytes.
    Rowe DT; Hall L; Joab I; Laux G
    J Virol; 1990 Jun; 64(6):2866-75. PubMed ID: 2159547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of a short Epstein-Barr virus DNA fragment in a B95-8 virus converted Burkitt lymphoma line expressing Epstein-Barr nuclear antigens EBNA2 and EBNA5.
    Trivedi P; Cuomo L; de Campos-Lima PO; Imreh MP; Kvarnung K; Klein G; Masucci MG
    J Gen Virol; 1993 Jul; 74 ( Pt 7)():1393-8. PubMed ID: 8393080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marked, transient inhibition of expression of the Epstein-Barr virus latent membrane protein gene in Burkitt's lymphoma cell lines by electroporation.
    Gahn TA; Sugden B
    J Virol; 1993 Nov; 67(11):6379-86. PubMed ID: 8411339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
    Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
    J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient expression of the Epstein-Barr virus LMP1 gene in human primary B cells induces cellular activation and DNA synthesis.
    Peng M; Lundgren E
    Oncogene; 1992 Sep; 7(9):1775-82. PubMed ID: 1354347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The level of c-fgr RNA is increased by EBNA-2, an Epstein-Barr virus gene required for B-cell immortalization.
    Knutson JC
    J Virol; 1990 Jun; 64(6):2530-6. PubMed ID: 2159528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle.
    Lear AL; Rowe M; Kurilla MG; Lee S; Henderson S; Kieff E; Rickinson AB
    J Virol; 1992 Dec; 66(12):7461-8. PubMed ID: 1331531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcription of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene occurs before induction of the BCR2 (Cp) EBNA gene promoter during the initial stages of infection in B cells.
    Schlager S; Speck SH; Woisetschläger M
    J Virol; 1996 Jun; 70(6):3561-70. PubMed ID: 8648690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.